Assessment of real-world performance of CELOX™ Rapid by trained emergency responders

POST MARKET SURVEILLANCE REPORT ON THE CLINICAL USE OF CELOX™ RAPID 

Clinical results of the latest post market surveillance survey on utilization of CELOX™ Rapid Hemostatic Gauze by emergency responders concluded that the CELOX™ Rapid range proves to be highly successful in controlling moderate to severe bleeding on a variety of wounds in the hands of various clinical personnel. 

• 100% success rate, 84/84 cases achieved hemostasis after the first application using CELOX™ Rapid – even those involving the most severe bleeding cases
• All respondents across the sub-analysis rated CELOX™ Rapid ‘good’ or ‘excellent’
• 100% safety record – no adverse event reported

The survey conclusion clearly demonstrates the effectiveness of CELOX™ Rapid in clinical practice despite the use of anticoagulants and in particular – in the high pressure and demanding environment of the Emergency Department.

The study covered 84 cases (a sub-analysis from the larger study of 292 cases) involving single or multiple wounds ranging from cutting / piercing and blunt trauma to gunshots and RTAs – 90% of which were described as involving ‘moderate to severe bleeding’, 21% were on anticoagulation therapy. There were no adverse events recorded.

Read the full user survey report